Millennium Management
BBNX

Millennium Management’s Beta Bionics BBNX Stock Holding History

Millennium Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.63M Sell
860,866
-84,595
-9% -$1.25M ﹤0.01% 2318
2025
Q4 		$28.8M Buy
945,461
+148,497
+19% +$3.97M 0.01% 1219
2025
Q3 		$15.8M Buy
796,964
+254,766
+47% +$4.48M 0.01% 1925
2025
Q2 		$7.89M Buy
+542,198
New +$7.68M ﹤0.01% 2513

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management's BBNX Position: Q1 2026 in Review

Millennium Management reduced its Beta Bionics (BBNX) stake by 8.9% in Q1 2026, selling an estimated $1.25M and leaving 860,866 shares worth $8.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

Millennium Management first reported a position in BBNX in Q2 2025 and has held it in 4 quarters since. The position peaked at $28.8M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Millennium Management held 860,866 shares of Beta Bionics worth $8.63M as of Q1 2026.
  • Millennium Management sold 84,595 Beta Bionics shares in Q1 2026, an estimated $1.25M.
  • Beta Bionics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2318 holding.
  • Millennium Management first reported a position in Beta Bionics in Q2 2025 and has held it in 4 quarters since.
  • Millennium Management's Beta Bionics position peaked at $28.8M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.